Evidence map›Paper›PMID 30268129›Full record

ArticleRespiratory research2018

Dual effects of human neutrophil peptides in a mouse model of pneumonia and ventilator-induced lung injury.

Junbo Zheng, Yongbo Huang, Diana Islam, Xiao-Yan Wen, Sulong Wu, Catherine Streutker, Alice Luo, Manshu Li, Julie Khang, Bing Han and 4 more

Open access · goldAbstract read
In one paragraph

Article in Respiratory research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Possible role of purinergic signaling in COVID-19.Molecular and cellular biochemistry · 2021
    Review
  7. Article
  8. P2 Purinergic Signaling in the Distal Lung in Health and Disease.International journal of molecular sciences · 2020
    Review
  9. Modulation of Human Neutrophil Peptides onJournal of inflammation research · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Junbo ZhengDepartment of Critical Care Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150000, Heilongjiang, China.
Yongbo HuangThe State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510000, Guangdong, China.
Diana IslamKeenan Research Center for Biomedical Science of St. Michael's Hospital, Toronto, ON, M5B 1W8, Canada.
Xiao-Yan WenKeenan Research Center for Biomedical Science of St. Michael's Hospital, Toronto, ON, M5B 1W8, Canada.
Sulong WuThe State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510000, Guangdong, China.
Catherine StreutkerKeenan Research Center for Biomedical Science of St. Michael's Hospital, Toronto, ON, M5B 1W8, Canada.
Alice LuoKeenan Research Center for Biomedical Science of St. Michael's Hospital, Toronto, ON, M5B 1W8, Canada.
Manshu LiThe State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510000, Guangdong, China.
Julie KhangKeenan Research Center for Biomedical Science of St. Michael's Hospital, Toronto, ON, M5B 1W8, Canada.
Bing HanKeenan Research Center for Biomedical Science of St. Michael's Hospital, Toronto, ON, M5B 1W8, Canada.
Nanshan ZhongThe State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510000, Guangdong, China.
Yimin LiThe State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510000, Guangdong, China. dryiminli@vip.163.com.
Kaijiang YuDepartment of Critical Care Medicine, The Third Affiliated Hospital of Harbin Medical University, Harbin, 150000, Heilongjiang, China. drkaijiang@163.com.
Haibo ZhangThe State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510000, Guangdong, China. zhangh@smh.ca.
St. Michael's Hospital · CAGuangzhou Medical University · CNFirst Affiliated Hospital of Guangzhou Medical University · CNSecond Affiliated Hospital of Harbin Medical University · CNState Key Laboratory of Respiratory Disease · CNThird Affiliated Hospital of Harbin Medical University · CNUniversity of Toronto · CA

Funding

National Natural Science Foundation of China 81361128003National Natural Science Foundation of China 81490534,81490530National Natural Science Foundation of China (CN) 81490534,81490530,81370177,81361128003
6 · The paper itself

Abstract

backgroundPneumonia is a major cause of high morbidity and mortality in critically illness, and frequently requires support with mechanical ventilation. The latter can lead to ventilator-induced lung injury characterized by neutrophil infiltration. The cationic human neutrophil peptides (HNP) stored in neutrophils can kill microorganisms, but excessive amount of HNP released during phagocytosis may contribute to inflammatory responses and worsen lung injury. Based on our previous work, we hypothesized that blocking the cell surface purinergic receptor P2Y

methodsPlasma HNP levels were measured in patients with pneumonia who received mechanical ventilation and in healthy volunteers. FVB littermate control and HNP transgenic (HNP

resultsPlasma HNP concentration increased in patients with pneumonia as compared to healthy subjects. The bacterial counts in the bronchoalveolar lavage fluid (BALF) were lower in HNP

conclusionsHNP exerted dual effects by exhibiting antimicrobial activity in pneumonia alone condition while enhancing inflammatory responses in pneumonia followed by HP mechanical ventilation. Blocking P2Y

Indexed as

Disease Models, AnimalNeutrophilsReceptors, Purinergic P2AgedAnimalsFemaleHumansIsothiocyanatesMaleMiceMice, TransgenicMiddle AgedPneumonia, Ventilator-AssociatedPseudomonas aeruginosaThioureaTreatment OutcomeIsothiocyanatesN,N''-1,4-butanediylbis(N'-(3-isothiocyanatophenyl))thioureapurinoceptor P2Y6Receptors, Purinergic P2ThioureaBacteria clearanceInflammationNeutrophilP2Y6 purinergic receptorVentilator-induced lung injuryα-Defensins

Identifiers

PMID30268129
PMCPMC6162902
OpenAlexW2893037972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.